New England Journal of Medicine

Vol. 394, Issue 6 Issue 6 2026
18
Articles

Articles in this Issue

Elective Cesarean Section for Maternal Preference

Abarna Pearl, Howard Minkoff, Gordon C.S. Smith Feb 05, 2026 pp. 603-605 10.1056/nejmclde2504787

More on Cold Perfusion vs. Static Cold Storage of Deceased-Donor Kidneys

Feb 05, 2026 pp. 622-623 10.1056/nejmc2517678

Exploring a New “Reef” in Dyslipidemic Risk Reduction

William E. Boden Feb 05, 2026 pp. 597-599 10.1056/nejme2516860

Freedom of Speech and the Viability of Science — Dr. Jeremiah Stamler’s Fight against HUAC

Gerald M. Oppenheimer, Sarah W. Tracy Feb 05, 2026 pp. 606-611 10.1056/nejmms2514344

Aortitis Due to Large-Vessel Vasculitis

Hsien-Tzung Liao, Ching-Lan Wu Feb 05, 2026 pp. 588-588 10.1056/nejmicm2513456

Beta-Blockers after Myocardial Infarction — Toward Personalized Management

Thomas F. Lüscher, Florian A. Wenzl Feb 05, 2026 pp. 599-602 10.1056/nejme2600427

A Matter of Time

Grant A. Wilson, Colin H. McLeish, Allan C. Gelber et al. Feb 05, 2026 pp. 589-595 10.1056/nejmcps2508389

Health Insurance after Corporatization — What Next?

Leemore Dafny Feb 05, 2026 pp. 521-523 10.1056/nejmp2415746

Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer

Sara M. Tolaney, Zefei Jiang, Qingyuan Zhang et al. Feb 05, 2026 pp. 551-562 10.1056/nejmoa2508668

Sevabertinib in Advanced <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Feb 05, 2026 pp. 621-622 10.1056/nejmc2517517

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer

Neal D. Shore, Murilo de Almeida Luz, Ugo De Giorgi et al. Feb 05, 2026 pp. 563-575 10.1056/nejmoa2510310

Floppy Eyelid Syndrome

Kara E. Shinder, Roman Shinder Feb 05, 2026 10.1056/nejmicm2512228

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting <i>ANGPTL3</i>

Feb 05, 2026 pp. 619-620 10.1056/nejmc2518635

Hypertonic Saline or Carbocisteine in Bronchiectasis

Feb 05, 2026 pp. 614-616 10.1056/nejmc2517516

Sacituzumab Govitecan in Advanced Triple-Negative Breast Cancer

Feb 05, 2026 pp. 620-621 10.1056/nejmc2517720

Spontaneous Heparin-Induced Thrombocytopenia after Total Hip Arthroplasty

Arielle L. Langer, Luke S. Vest, Jean M. Connors et al. Feb 05, 2026 pp. 612-614 10.1056/nejmc2513813

Using FDA Law to Threaten Medical Practice

Lewis A. Grossman, Nathan G. Cortez, Patricia J. Zettler Feb 05, 2026 pp. 524-525 10.1056/nejmp2516086

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

Ann Marie Navar, Elina Mikhailova, Alberico L. Catapano et al. Feb 05, 2026 pp. 529-539 10.1056/nejmoa2511002

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page